Health Care·Biotechnology·$5.5B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.67 | N/A | -6.69% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.67 | N/A | -6.69% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management expressed concern over current market conditions and their impact on performance. They highlighted a commitment to navigating these challenges.
Management acknowledged the challenges faced during the quarter.
They emphasized ongoing efforts to improve operational efficiency.
The earnings report indicates that Scholar Rock is still facing difficulties, particularly reflected in their EPS miss. The stock's 2.74% decline suggests investor disappointment in the results and lack of guidance. Without clear direction from management, uncertainty may linger in the market regarding the company's future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
FOX CORP Class A
May 12, 2025